In the Clinic: ART and Metabolic Effects

Volume 4, Issue 4.

The incidence of the metabolic complications common in people with HIV infection — bone disease, weight gain, cardiovascular disease, and liver disease — is increasing as improved antiretroviral therapies create longer lifespans.

In this issue, Dr. Suman Srinivasa and nurse practitioner Kathleen Fitch from Harvard Medical School discuss how to identify and manage these metabolic complications to help improve outcomes and quality of life in patients living with HIV.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

In the Clinic: Identifying & Managing HCV Complications

Volume 6, Issue 2.

In this podcast Andrea Granados, MD describes the clinical impact of the early diagnosis of glucose abnormalities in people with CF, summarizes the limitations of alternative modalities for screening and diagnosing CFRD, and and identifies the current recommendations for the management of CFRD.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

Lung Transplant and CRC Screening

Volume 8, Issue 2.

Screening to avoid the morbidity and mortality of colorectal cancer (CRC) in patients with CF, with the incidence of CRC rising, has become an increasingly important challenge, particularly among lung transplant patients.  But how and when should patients be screened? With colonoscopy or non-invasive FIT? Before or after transplant?  Are there patients who should not be screened, and why?

In this issue, Dr. Denis Hadjiliadis from the Perelman School of Medicine at the University of Pennsylvania discusses the clinical aspects of screening patients with CF to prevent CRC.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

In the Clinic: The New Ultralong-Acting Insulins

Volume 3, Issue 12.

In this podcast, Dr. Roma Gianchandani from the University of Michigan identifies scenarios in which patients can benefit from ultralong-acting insulins and discuss the potential negatives of ultralong-acting insulins.

Take our post-test to claim CME credits:
Physician post-test
Nurse post-test

To read a companion newsletter click here.

New ART Agents: A Clinical Perspective

Volume 4, Issue 2.

Recently approved treatment options and new antiviral therapies still under investigation — through case-based discussion, Dr. Ethel Weld from the Division of Clinical Pharmacology and Infectious Diseases at the Johns Hopkins University School of Medicine explains how the promise of these new agents can impact current clinical practice.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

Pulmonary Hypertension: Clinical Workup & Diagnosis

Volume 1, Issue 6.

In this podcast Dr. Paul Hasson from Johns Hopkins explains the complexity of pulmonary hypertension
and the importance of a rigorous diagnostic workup and describes the basic diagnostic algorithm to accurately classify the type of pulmonary hypertension encountered in a specific patient.

Take our post-test to claim CME credits:
Physician post-test
Nurse post-test

To read a companion newsletter click here.

Clinical Implications of CGM in Patients with Type 2

Volume 3, Issue 10.

In this podcast, Dr. Roma Gianchandani from the University of Michigan identifies scenarios in which patients can benefit from ultralong-acting insulins and discuss the potential negatives of ultralong-acting insulins.

Take our post-test to claim CME credits:
Physician post-test
Nurse post-test

To read a companion newsletter click here.

Intensifying Glycemic Therapy with a Fixed Ratio Basal Insulin/GLP-1 RA Combination

Volume 3, Issue 8.

In this podcast Dr. Anders Carlson from the University of Minnesota Medical School discusses the clinical implications of continuous glucose monitoring (CGM) in patients with type 2 diabetes.

Take our post-test to claim CME credits:
Physician post-test
Nurse post-test

To read a companion newsletter click here.